Quantum-Si prices $50 million stock offering at $1.67 per share

Quantum-Si Incorporated (NASDAQ: QSI) announced Thursday evening that it has entered into a securities purchase agreement with a single institutional investor for a registered direct offering of 29,940,119 shares of common stock at $1.67 per share.

The proteomics technology company expects to receive gross proceeds of approximately $50 million before deducting placement agent commissions and other offering expenses. The closing is expected to occur on or about July 8, 2025, subject to customary closing conditions.

The company plans to use the net proceeds for working capital and general corporate purposes, according to the press release.

A.G.P./Alliance Global Partners is serving as the sole placement agent for the offering.

The offering is being conducted under an effective shelf registration statement on Form S-3 that was declared effective by the Securities and Exchange Commission on August 22, 2023. A final prospectus supplement and accompanying prospectus will be filed with the SEC.

Quantum-Si develops proteomics technology focused on single-molecule protein analysis. The company's platform enables real-time kinetic-based detection for protein research applications.

You May Also Be Interested In

• Heartflow (HTFL) Files for Proposed IPO
• RYVYL closes $6 million public offering of shares and warrants
• Mobile-health Network Solutions launches $300 million equity offering